Cross-tissue multiomics reveals that Akkermansia muciniphila counteracts metabolic syndrome by reprograming gut microbiota, oleoylethanolamide and the gut-hypothalamus axis
This study demonstrates that *Akkermansia muciniphila* alleviates fructose-induced metabolic syndrome by reprogramming the gut microbiota and metabolome to elevate oleoylethanolamide levels, which subsequently activates the gut-hypothalamus axis to improve metabolic health.